Cancer Research Technology has an impressive range of over 200 oncology-focused projects under development and potentially available for licensing.
CRT has today launched Acublate Limited, a spin-out company which will develop a next-generation High Intensity Focused Ultrasound (HIFU) surgery device to treat a range of solid tumour types. Read more ›
© Cancer Research Technology 2012